Mereo BioPharma Group (MREO) Leases: 2022-2025
Historic Leases for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to $378,000.
- Mereo BioPharma Group's Leases fell 58.42% to $378,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $378,000, marking a year-over-year decrease of 58.42%. This contributed to the annual value of $727,000 for FY2024, which is 41.61% down from last year.
- According to the latest figures from Q3 2025, Mereo BioPharma Group's Leases is $378,000, which was down 27.59% from $522,000 recorded in Q2 2025.
- Mereo BioPharma Group's Leases' 5-year high stood at $1.7 million during Q4 2022, with a 5-year trough of $378,000 in Q3 2025.
- Moreover, its 3-year median value for Leases was $818,000 (2024), whereas its average is $812,125.
- Data for Mereo BioPharma Group's Leases shows a maximum YoY slumped of 58.42% (in 2025) over the last 5 years.
- Over the past 4 years, Mereo BioPharma Group's Leases (Quarterly) stood at $1.7 million in 2022, then declined by 26.76% to $1.2 million in 2023, then slumped by 41.61% to $727,000 in 2024, then crashed by 58.42% to $378,000 in 2025.
- Its last three reported values are $378,000 in Q3 2025, $522,000 for Q2 2025, and $622,000 during Q1 2025.